Our study highlights anti-ETAR and anti-ETBR autoantibodies as potential novel signaling moieties in SLE associated with blood pressure dysregulation, endothelial activation, and distinct vascular biomarker profiles. The gene discussed is EDNRA; the disease is systemic lupus erythematosus.